What is Atlas5D?
Atlas5D specializes in the development of an Ambient Measurement System designed to assess health and wellness metrics through motion analysis in various environments. The company's core technology facilitates passive, automated monitoring for individuals, healthcare institutions, and clinical settings. By eliminating the need for active user engagement, the system provides a seamless method for tracking daily routines and critical health indicators. The platform is both clinically validated and AI-enabled, ensuring that privacy remains a priority while delivering precise, actionable data. This unique approach empowers healthcare providers and individuals alike to make informed decisions based on real-world, longitudinal health insights.
How much funding has Atlas5D raised?
Atlas5D has raised a total of $3M across 1 funding round:
Series A
$3M
Series A (2016): $3M with participation from GreyBird Ventures, LLC
Key Investors in Atlas5D
GreyBird Ventures, LLC
GreyBird Ventures is an investment firm focused on unique diagnostic technologies in the era of precision medicine, managing a portfolio that includes companies like Angstrom Bio and Platomics.
What's next for Atlas5D?
With the infusion of this major strategic investment, Atlas5D is expected to focus on the commercial scaling of its ambient monitoring infrastructure. The company will likely prioritize the integration of its AI-enabled diagnostic tools into broader healthcare ecosystems, enhancing the interoperability of its data with existing electronic health records. Furthermore, the capital will support ongoing clinical validation efforts, ensuring that the system meets the rigorous standards required for widespread adoption in hospital and assisted-living environments. As Atlas5D continues to refine its algorithms, the focus will remain on maintaining high-fidelity data capture while navigating the complexities of global health data privacy regulations.
See full Atlas5D company page
